IV 
117TH CONGRESS 
1ST SESSION 
H. RES. 280 
Expressing the sense of the House of Representatives that decades of policies 
rooted in socialism have stifled United States domestic pharmaceutical 
drug manufacturing and left the United States exposed to the hostile 
actions and unfair trade practices of the People’s Republic of China. 
IN THE HOUSE OF REPRESENTATIVES 
MARCH 26, 2021 
Mr. JACKSON (for himself, Mr. BANKS, Mr. C. SCOTT FRANKLIN of Florida, 
Ms. HERRELL, Mr. MAST, Mr. BAIRD, Ms. TENNEY, Mr. HICE of Geor-
gia, Ms. SALAZAR, Mr. MCCLINTOCK, and Mr. ROY) submitted the fol-
lowing resolution; which was referred to the Committee on Ways and 
Means, and in addition to the Committees on Foreign Affairs, and En-
ergy and Commerce, for a period to be subsequently determined by the 
Speaker, in each case for consideration of such provisions as fall within 
the jurisdiction of the committee concerned 
RESOLUTION 
Expressing the sense of the House of Representatives that 
decades of policies rooted in socialism have stifled United 
States domestic pharmaceutical drug manufacturing and 
left the United States exposed to the hostile actions 
and unfair trade practices of the People’s Republic of 
China. 
Whereas until the recent enactment of the Tax Cuts and 
Jobs Act, the United States had one of the least competi-
tive tax systems in the world, causing decades of manu-
VerDate Sep 11 2014 
22:51 Mar 29, 2021
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6300
E:\BILLS\HR280.IH
HR280
kjohnson on DSK79L0C42PROD with BILLS
•HRES 280 IH 
facturing job losses and increased offshoring of vital in-
dustries; 
Whereas the over $2,000,000,000,000 of annual economic 
output lost due to the cost imposed by Federal regulatory 
action would, by itself, be the 15th largest economy; 
Whereas the crushing $28,000,000,000,000 Federal debt has 
drained United States credit markets, starving Americans 
and American businesses of needed funding to expand 
operations and modernize factories; 
Whereas the left has, for decades, sought to expand these 
burdens and barriers of the Federal Government to pro-
mote its radical agenda, depleting America of its indus-
trial base; 
Whereas the pharmaceutical industry has been particularly 
affected by the negative effects of these anticompetitive 
socialist policies, driving up prices and forcing private in-
dustry to offshore manufacturing processes; 
Whereas the novel coronavirus (COVID–19) outbreak com-
pounded national security and public health concerns and 
highlighted potential vulnerabilities regarding the Amer-
ican health care system’s reliance on foreign nations, par-
ticularly China, for medical supplies and pharmaceuticals; 
Whereas the Communist Chinese regime has sought to take 
advantage of these burdens and use its own tariffs, sub-
sidies, and anticompetitive policies to gain a comparative 
advantage in the manufacturing of active pharmaceutical 
ingredients; 
Whereas, in September 2018, the Department of Defense 
published a study titled ‘‘Assessing and Strengthening 
the Manufacturing and Defense Industrial Base and Sup-
ply Chain Resiliency of the United States’’, which identi-
VerDate Sep 11 2014 
22:51 Mar 29, 2021
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6300
E:\BILLS\HR280.IH
HR280
kjohnson on DSK79L0C42PROD with BILLS
•HRES 280 IH 
fied several national security risks associated with Chi-
na’s anticompetitive, protectionist trade policies; 
Whereas the 2018 National Defense Strategy clearly states 
that the central challenge to the prosperity, security, and 
success of the United States is China’s authoritarian 
model and long-term strategic competition; 
Whereas China is also leveraging military modernization and 
predatory economics to reorder the Indo-Pacific region to 
its advantage and to displace the United States in its ef-
forts for global dominance; 
Whereas, in October 2019, the Food and Drug Administra-
tion testified that China has increased production of ac-
tive pharmaceutical ingredients over the past decade, 
driven by industry desire for cost-savings and less strin-
gent regulatory structures; 
Whereas in that testimony, the Food and Drug Administra-
tion noted that current data capabilities leave gaps in un-
derstanding the exact volume of foreign-sourced active 
pharmaceutical ingredients being used for domestic 
drugs, the volume being produced at Chinese facilities, 
and where Chinese active pharmaceutical ingredients are 
being distributed worldwide; 
Whereas China intends to continue using United States self- 
imposed economic constraints to push the United States 
out of global affairs and to dismantle the free market 
structures that have lead to unprecedented global pros-
perity; 
Whereas the threat imposed by China is dependent on the 
United States continuing decades of domestic policies 
that have stifled development and crippled the United 
States manufacturing base; and 
VerDate Sep 11 2014 
22:51 Mar 29, 2021
Jkt 019200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6300
E:\BILLS\HR280.IH
HR280
kjohnson on DSK79L0C42PROD with BILLS
•HRES 280 IH 
Whereas the people and industries of the United States pos-
sess the skillsets, tools, and innovative spirit to restore 
the United States pharmaceutical manufacturing base 
and to fully counter the unfair and anticompetitive prac-
tices of the Communist Chinese regime: Now, therefore, 
be it 
Resolved, That the House of Representatives— 
(1) commits to the competitive free market and 
free trade policies that allowed the United States to 
become the wealthiest and most advanced Nation on 
Earth; 
(2) commits to combating, through the use of 
free market policies, the present national security 
threat caused by the Communist Chinese regime and 
its attacks on the United States pharmaceutical 
manufacturing base; and 
(3) urges the United States Government to— 
(A) remove the Federal tax, regulatory, 
and debt burdens and barriers that have weak-
ened the United States pharmaceutical manu-
facturing base; 
(B) empower the United States Trade 
Representative to call on the international com-
munity, to adopt competitive free trade and free 
market policies, and to counter the harmful and 
unfair trade practices of the Communist Chi-
nese regime; 
VerDate Sep 11 2014 
22:51 Mar 29, 2021
Jkt 019200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\HR280.IH
HR280
kjohnson on DSK79L0C42PROD with BILLS